Science Explorer Back to mapMap
Discussion
Researcher · Ministry of Health of the Russian Federation · Russia

Pavel V. Kononets

Pavel V. Kononets publishes mostly in Pulmonary and Respiratory Medicine, Surgery and Oncology, on topics such as Gastric Cancer Management and Outcomes, Lung Cancer Diagnosis and Treatment and Lung Cancer Treatments and Mutations.

ORCID 0000-0003-4744-6141 OpenAlex
World rank
#7,664,225
of 7,710,434 ranked researchers
Rank in Russia
#174,537
of 179,717
Works
71
Citations
146
Citations per work
2.1
h-index
7
i10-index 5Top 71% in Pulmonary and Respiratory Medicine
Pavel V. Kononets

What does Pavel V. Kononets research?

Pavel V. Kononets's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (4%).

Health Sciences: 49 works · 69.2% of their workMedicine: 49 works · 69.2% of their workPulmonary and Respiratory Medicine: 23 works · 32.2% of their workSurgery: 12 works · 16.8% of their workOncology: 9 works · 12.5% of their workCardiology and Cardiovascular Medicine: 3 works · 4.3% of their workEpidemiology: 2 works · 3.4% of their workEverything else: 19 works · 27.0% of their workLife Sciences: 3 works · 3.8% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 3.8% of their workMolecular Biology: 3 works · 3.8% of their workTHEIR WORKPavel V. Kononets71works
Life Sciences4%Health Sciences69%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4969.2%
  2. Everything else1927.0%
    1. Biochemistry, Genetics and Molecular Biology33.8%
  1. 1Pulmonary and Respiratory Medicine32% of their works
  2. 2Surgery17% of their works
  3. 3Oncology12% of their works
  4. 4Cardiology and Cardiovascular Medicine4% of their works
  5. 5Molecular Biology4% of their works
  6. 6Epidemiology3% of their works

Research topics

Which keywords describe Pavel V. Kononets's research?

The keywords of their largest research topics: Chemotherapy, Adjuvant Therapy, Endoscopic Resection, Clinical Practice Guidelines, Gastric Cancer, Molecular Characterization, Clinical Trials and Targeted Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Chemotherapy434 topics
  2. Adjuvant Therapy292 topics
  3. Endoscopic Resection272 topics
  4. Clinical Practice Guidelines252 topics
  5. Gastric Cancer181 topic
  6. Molecular Characterization181 topic
  7. Clinical Trials172 topics
  8. Targeted Therapy172 topics
  9. Prognostic Factors142 topics
  10. CT Screening111 topic
  11. Lung Cancer111 topic
  12. ALK Inhibitors101 topic
  13. EGFR Mutations101 topic
  14. Esophageal Carcinoma91 topic
  15. Preoperative Chemoradiotherapy91 topic
  16. Immune Checkpoint Blockade81 topic
  17. Lung Tumors81 topic
  18. Metastatic Carcinomas81 topic
  19. PD-1 and PD-L181 topic
  20. Genomic Profiles71 topic
  21. Osteosarcoma71 topic
  22. Small-Cell Lung Cancer71 topic
  23. Soft Tissue Sarcoma71 topic

Where does Pavel V. Kononets work?

Pavel V. Kononets's main affiliation in the publication record is Ministry of Health of the Russian Federation, Russia.

How many publications and citations does Pavel V. Kononets have?

OpenAlex counts 71 works and 146 citations for Pavel V. Kononets, an h-index of 7, ranking #7,664,225 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Pavel V. Kononets. Posts are plain text and can be reported.